Distributional Impact of Rotavirus Vaccination in 25 GAVI Countries: Estimating Disparities in Benefits and Cost-Effectiveness
This article, published in Vaccine, reports on an analysis that combines the results of a country-level model of rotavirus vaccination published elsewhere with data from Demographic and Health Surveys on within-country patterns of vaccine coverage and diarrhea mortality risk factors to estimate within-country distributional effects of rotavirus vaccination. The study examined 25 countries eligible for funding through the GAVI Alliance. The authors concluded that rotavirus vaccination is most cost-effective in low-income groups and regions. However, in many countries, simply adding new vaccines to existing systems targets investments to higher-income children, due to disparities in vaccination coverage. Therefore, maximizing health benefits for the poorest children and value for money require increased attention to these distributional effects. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Rheingans R, Atherly D, Anderson J
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Rheingans R, Atherly D, Anderson J. Distributional Impact of Rotavirus Vaccination in 25 GAVI Countries: Estimating Disparities in Benefits and Cost-Effectiveness. Vaccine. 2012;30(Supplement 1):A15-A23.